FFA
BIIB icon

Founders Financial Alliance’s Biogen BIIB Stock Holding History

Founders Financial Alliance’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-872
Closed -$224K – 492
2023
Q3 		$224K Sell
872
-58
-6% -$15.5K 0.1% 204
2023
Q2 		$265K Buy
930
+70
+8% +$20.8K 0.1% 209
2023
Q1 		$253K Sell
860
-26
-3% -$7.19K 0.13% 171
2022
Q4 		$245K Sell
886
-72
-8% -$20.3K 0.11% 190
2022
Q3 		$256K Buy
+958
New +$203K 0.13% 171
2022
Q1 		– Sell
-1,244
Closed -$298K – 443
2021
Q4 		$298K Buy
+1,244
New +$320K 0.12% 181
2021
Q3 		– Sell
-1,175
Closed -$407K – 459
2021
Q2 		$407K Buy
1,175
+22
+2% +$6.67K 0.19% 126
2021
Q1 		$322K Sell
1,153
-81
-7% -$21.8K 0.16% 148
2020
Q4 		$304K Buy
1,234
+1,229
+24,580% +$317K 0.17% 136
2020
Q3 		$1K Buy
+5
New +$1.4K ﹤0.01% 1266

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Founders Financial Alliance's BIIB Position: Q4 2023 in Review

Founders Financial Alliance sold out of Biogen (BIIB) in Q4 2023, closing a stake of 872 shares — an estimated $224K sold.

Founders Financial Alliance first reported a position in BIIB in Q3 2020 and held it in 10 quarters. The position peaked at $407K in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Founders Financial Alliance reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Founders Financial Alliance sold 872 Biogen shares in Q4 2023, an estimated $224K.
  • Founders Financial Alliance first reported a position in Biogen in Q3 2020 and held it in 10 quarters.
  • Founders Financial Alliance's Biogen position peaked at $407K in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Founders Financial Alliance's 13F filing for Q4 2023, filed 9 Feb 2024.